Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Testosterone Enanthate Generic Name & Formulations
Legal Class
CIII
General Description
Testosterone enanthate 200mg/mL; IM inj; in sesame oil; contains chlorobutanol.
Pharmacological Class
Androgen.
How Supplied
Contact supplier
Manufacturer
Testosterone Enanthate Indications
Indications
Advancing inoperable metastatic mammary cancer in females who are 1–5 years postmenopausal.
Testosterone Enanthate Dosage and Administration
Adult
Give by deep IM inj into gluteal muscle. 200–400mg once every 2–4 weeks. Max 400mg/month. Monitor closely.
Children
Not established.
Testosterone Enanthate Contraindications
Contraindications
Male breast or prostate cancer. Pregnancy (Cat.X).
Testosterone Enanthate Boxed Warnings
Not Applicable
Testosterone Enanthate Warnings/Precautions
Warnings/Precautions
Discontinue if jaundice, abnormal liver function, hypercalcemia, or edema occurs. Monitor liver function, hemoglobin, hematocrit, cholesterol, urine and serum calcium. Preexisting cardiac, renal or hepatic disease (discontinue if edema occurs). History of MI or coronary artery disease. Monitor for venous thromboembolism; discontinue if suspected. Elderly. Nursing mothers: not recommended.
Testosterone Enanthate Pharmacokinetics
See Literature
Testosterone Enanthate Interactions
Interactions
May potentiate oral anticoagulants, oxyphenbutazone. May alter insulin requirements. Increased risk of edema with ACTH, corticosteroids. May affect thyroid levels.
Testosterone Enanthate Adverse Reactions
Adverse Reactions
Amenorrhea, menstrual irregularities, inhibition of gonadotropin secretion, virilization; others: inj site reactions, peliosis hepatis, edema, hepatic carcinoma, nausea, jaundice, hirsutism, acne, polycythemia, headache, anxiety, depression, paresthesia, altered libido, fluid and electrolyte disturbances, suppression of clotting factors, increased serum cholesterol.
Testosterone Enanthate Clinical Trials
See Literature
Testosterone Enanthate Note
Notes
Formerly known under the brand name Delatestryl.
Testosterone Enanthate Patient Counseling
See Literature
Testosterone Enanthate Generic Name & Formulations
Legal Class
CIII
General Description
Testosterone enanthate 200mg/mL; IM inj; in sesame oil; contains chlorobutanol.
Pharmacological Class
Androgen.
How Supplied
Contact supplier
Manufacturer
Testosterone Enanthate Indications
Indications
Testosterone replacement therapy in adult males with congenital or acquired primary hypogonadism or hypogonadotropic hypogonadism. To stimulate puberty in males with delayed puberty.
Limitations of Use
Not established in men with age-related hypogonadism.
Testosterone Enanthate Dosage and Administration
Adult
Prior to treatment, confirm diagnosis by ensuring serum testosterone is below normal range as measured in the AM on at least 2 separate days. Give by deep IM inj into gluteal muscle once every 2–4 weeks. Male hypogonadism: 50–400mg. Delayed puberty: 50–200mg. Max 400mg/month.
Children
See full labeling.
Testosterone Enanthate Contraindications
Contraindications
Male breast or prostate cancer. Pregnancy (Cat.X).
Testosterone Enanthate Boxed Warnings
Not Applicable
Testosterone Enanthate Warnings/Precautions
Warnings/Precautions
Discontinue if jaundice, abnormal liver function, hypercalcemia, or edema occurs. Monitor liver function, hemoglobin, hematocrit, prostate specific antigen (PSA), cholesterol, bone age (every 6 months for pre-pubertal males). Preexisting cardiac, renal or hepatic disease (discontinue if edema occurs). History of MI or coronary artery disease. May increase risk of prostatic hypertrophy or carcinoma in elderly. Testosterone and/or other anabolic androgenic steroid abuse. Monitor for venous thromboembolism; discontinue if suspected. Inform patients of possible increased risk of MI, stroke. Elderly. Young children. Nursing mothers: not recommended.
Testosterone Enanthate Pharmacokinetics
See Literature
Testosterone Enanthate Interactions
Interactions
May potentiate oral anticoagulants, oxyphenbutazone. May alter insulin requirements. Increased risk of edema with ACTH, corticosteroids. May affect thyroid levels.
Testosterone Enanthate Adverse Reactions
Adverse Reactions
Inj site reactions, peliosis hepatis, edema, hepatic carcinoma, prostatic hypertrophy or carcinoma, gynecomastia, priapism, oligospermia, nausea, jaundice, hirsutism, virilization, male pattern baldness, acne, polycythemia, headache, anxiety, depression, paresthesia, altered libido, fluid and electrolyte disturbances, suppression of clotting factors, increased serum cholesterol.
Testosterone Enanthate Clinical Trials
See Literature
Testosterone Enanthate Note
Notes
Formerly known under the brand name Delatestryl.
Testosterone Enanthate Patient Counseling
See Literature
